What You Ought to Know:
– AngelEye Health (“AngelEye” or the “Firm”), a supplier of affected person and household engagement options for hospital neonatal, pediatric intensive care, and nursery items, introduced the completion of its Sequence B funding, bringing the Firm’s funding so far to roughly $20M. The Sequence B spherical was led by by Brad Whitmore and Mountain Group Companions (“MGP”), with participation from SeedtoB Capital and the Rash Household Workplace.
– The Nashville, TN-based firm plans to make use of that newest spherical of funding to speed up the group’s speedy enlargement, together with rising its workforce of expertise and increasing its product analysis and growth perform.
HIPAA-Compliant Affected person Engagement Options Platform
Since its launch in 2014, AngelEye has constructed a various portfolio of assets designed to assist the present and future wants of the extremely specialised NICU and PICU. The Firm’s present providing consists of 4 complementary options accessible on AngelEye’s complete HIPAA-compliant platform that options superior communication and engagement assets for NICU scientific groups and the households that they assist.
Up to now three years alone, the Firm has grown exponentially, greater than tripling its annual income, rising its worker base to 39, a 5x enhance since 2018, and increasing its in depth shopper record to 125+ companions throughout the U.S. With the proceeds from this Sequence B funding, AngelEye is well-positioned to develop on that success, rising its product providing and buyer base to make sure that its hospital companions’ wants are met. In 2022, AngelEye is on tempo to ship practically 10 million digital bedside visits.
“AngelEye Well being understands the important position that family-integrated care performs in all elements of neonatal and pediatric care, and, as a company, we’re so happy with what we’ve achieved so far making this a tangible actuality for the hospital companions we serve,” stated Christopher Rand, CEO, AngelEye Well being. “We’re trying ahead to constructing off this success by persevering with to develop and refine our product portfolio in an effort to meet the evolving wants of the hospital companions we serve.”